![What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained](https://healthmattersio.files.wordpress.com/2019/06/ebv-ab-vca-igm.png?w=2000&h=1200&crop=1)
What is EBV Ab VCA, IgM? High and low values | Lab results explained – HealthMatters.io – Lab results explained
Early Virological and Immunological Events in Asymptomatic Epstein-Barr Virus Infection in African Children | PLOS Pathogens
![T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM](https://www.nejm.org/na101/home/literatum/publisher/mms/journals/content/nejm/1988/nejm_1988.318.issue-12/nejm198803243181203/20130822/images/img_medium/nejm198803243181203_t2.jpeg)
T-Cell Lymphomas Containing Epstein–Barr Viral DNA in Patients with Chronic Epstein–Barr Virus Infections | NEJM
![Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/3fe858fb-e8d7-4e44-8313-377d5af2e629/bjh14339-tbl-0003-m.jpg)
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
![A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-26912-6/MediaObjects/41467_2021_26912_Fig1_HTML.png)
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
![Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-97707-4/MediaObjects/41598_2021_97707_Fig1_HTML.png)
Epidemiological risk factors associated with primary infection by Epstein–Barr virus in HIV-1-positive subjects in the Brazilian Amazon region | Scientific Reports
![A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41467-021-26912-6/MediaObjects/41467_2021_26912_Fig2_HTML.png)
A potent and protective human neutralizing antibody targeting a novel vulnerable site of Epstein-Barr virus | Nature Communications
![Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews](https://journals.asm.org/cms/10.1128/CMR.00044-10/asset/cc13d41f-0a67-42c6-b353-bcc2d249468e/assets/graphic/zcm9990923420002.jpeg)
Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections | Clinical Microbiology Reviews
Study Of Epstein Barr Virus (Eby) Antibodies: IgG AND lgM Anti -VCA, lgG Anti-Ea and lg Anti-Ebna Obtained with an Original Micr
![Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS](https://www.pnas.org/cms/10.1073/pnas.221439999/asset/49d6b8e9-916c-4292-9792-14807c75653b/assets/graphic/pq2214399003.jpeg)
Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS
Cytomegalovirus and Epstein-Barr Infections: Prevalence and Impact on Patients with Hematological Diseases
IMMUNE RESPONCE TO EPSTEIN-BARR VIRUS INFECTION IN JUVENILE POPULATION WITH INFECTIOUS MONONUCLEOSIS SYNDROME
![Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS](https://www.pnas.org/cms/10.1073/pnas.221439999/asset/ad92fa7d-1442-424a-8df8-e0d61e83b5e1/assets/graphic/pq2214399002.jpeg)
Control of Epstein–Barr virus reactivation by activated CD40 and viral latent membrane protein 1 | PNAS
![Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text](https://neoscriber.org/cdn/serve/314b2/89ce7226890a9816c6245188fa8db84610291c13/jkums-23-2-84967-i004-preview.png)
Seroprevalence of Epstein-Barr Virus in HIV-Infected Patients, A Case Control Study | Journal of Kermanshah University of Medical Sciences | Full Text
![Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay](https://oaepublishstorage.blob.core.windows.net/6703493e-b300-4924-9aec-8fa220ad10df/70.fig.1.png)
Detection of Epstein-Barr virus infection subtype in patients with multiple sclerosis by indirect immunofluorescence assay
![Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/17deb256-0db6-484c-8313-bdd8fe4938fe/bjh14339-fig-0001-m.jpg)
Severe Epstein–Barr virus infection in primary immunodeficiency and the normal host - Worth - 2016 - British Journal of Haematology - Wiley Online Library
![Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008 - Annals of Oncology Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008 - Annals of Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/171aa832-6c3a-4d11-b872-6347be6a5b5d/gr1.jpg)
Epstein–Barr virus-associated lymphoproliferative disease in non-immunocompromised hosts: a status report and summary of an international meeting, 8–9 September 2008 - Annals of Oncology
![Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus | Italian Journal of Pediatrics | Full Text Clinical warning of hemophagocytic syndrome caused by Epstein-Barr virus | Italian Journal of Pediatrics | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13052-020-00949-7/MediaObjects/13052_2020_949_Fig1_HTML.png)